Charles River Laboratories International, Inc. Profile Avatar - Palmy Investing

Charles River Laboratories International, Inc.

Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It …
Medical - Diagnostics & Research
US, Wilmington [HQ]
CRL/Financial Reporting

Income Statements

15 Sheets · Starting from 2023
In Million USD. Margins, Growth Rates In %
Metric 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Revenue
1,202.00 1,133.00 1,142.00 1,129.00 1,165.00 1,297.00 1,363.00 1,681.00 1,857.00 2,266.00 2,621.00 2,923.00 3,540.00 3,976.00 4,129.00
EPS
1.75 -5.38 2.16 2.03 2.15 2.72 3.21 3.29 2.60 4.72 5.17 7.35 7.77 9.57 9.27
Profit
429.00 384.00 402.00 392.00 394.00 472.00 531.00 646.00 702.00 840.00 958.00 1,073.00 1,334.00 1,462.00 1,502.00
Pre Tax
149.00 -334.00 132.00 129.00 138.00 177.00 195.00 222.00 296.00 281.00 304.00 447.00 480.00 622.00 581.00
ETR
26.64 -0.01 12.92 21.29 23.79 26.84 22.20 29.98 57.71 19.33 16.45 18.30 17.03 20.93 17.36
Net
114.00 -336.00 109.00 97.00 102.00 126.00 149.00 154.00 123.00 226.00 252.00 364.00 390.00 486.00 474.00
EBITDA
193.00 122.00 196.00 183.00 169.00 203.00 230.00 292.00 368.00 410.00 563.00 768.00 820.00 986.00 1,032.00
Operating Income
166.00 -298.00 174.00 165.00 151.00 177.00 206.00 237.00 287.00 331.00 351.00 432.00 589.00 650.00 617.00
Interest Income
1.00 1.00 1.00 - - - - 1.00 1.00 1.00 - - - - 1.00 - - - - - - 5.00
Loss
-1,035.00 -1,035.00 -968.00 -963.00 -1,014.00 -1,119.00 -1,156.00 -1,444.00 -1,570.00 -1,934.00 -2,270.00 -2,491.00 -2,950.00 -3,325.00 -3,512.00
Cost of Revenue
-773.00 -748.00 -740.00 -737.00 -770.00 -825.00 -832.00 -1,034.00 -1,155.00 -1,426.00 -1,662.00 -1,850.00 -2,205.00 -2,513.00 -2,626.00
Operating Expenses
-262.00 -286.00 -227.00 -226.00 -243.00 -294.00 -324.00 -409.00 -414.00 -508.00 -607.00 -640.00 -744.00 -811.00 -885.00
Depreciation and Amortization
-93.00 -93.00 -85.00 -81.00 -96.00 -96.00 -94.00 -126.00 -131.00 -161.00 -198.00 -234.00 -265.00 -303.00 -314.00
Interest Expenses
-21.00 -34.00 -41.00 -33.00 -20.00 -11.00 -15.00 -27.00 -29.00 -63.00 -60.00 -86.00 -73.00 -59.00 -136.00
Other Expenses
-2.00 -397.00 - - -3.00 -7.00 -10.00 -3.00 -11.00 -38.00 -13.00 -47.00 -14.00 -109.00 -27.00 -95.00
WA Shares Outstanding
65.00 62.00 50.00 47.00 47.00 46.00 46.00 47.00 47.00 47.00 48.00 49.00 50.00 50.00 51.00
End of CRL's Analysis
CIK: 1100682 CUSIP: 159864107 ISIN: US1598641074 LEI: - UEI: -
Secondary Listings
CRL has no secondary listings inside our databases.